Minka J. A. Vries - Concepedia

Author

Minka J. A. Vries

Also Known As

M. J. A. Vries, Minka J A Vries, Minka J. A. Vries, Minka J. Vries, Minka J.A. Vries, Minka Vries, Patrick Thomas, Vries, Minka J. A.

Publications

951

Citations

H-Index

Concepts

All Affiliations

Maastricht University Maastricht University Medical Centre MRC Biostatistics Unit University of Cambridge Cambridge University Hospitals NHS Foundation Trust

About

Minka J. A. Vries is an author at Maastricht University specializing in hematology, thrombosis, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	26
2	Hematology	2	2	26
3	Emergency Medicine	1	1	13
4	Pharmacology	1	1	13
5	Percutaneous Coronary Intervention	1	1	13

Minka J. A. Vries

Publications

657

Citations

H-Index

Page 1

	Year	Citations
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders Kate Downes, Karyn Mégy, Daniel Duarte, Blood	2019	210
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders Ilenia Simeoni, Jonathan Stephens, Fengyuan Hu, Blood	2016	182
Screening for platelet function disorders with Multiplate and platelet function analyzer Floor CJI Moenen, Minka J. A. Vries, Patricia J. Nelemans, Platelets	2017	67
Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice Minka J. A. Vries, Paola E. J. van der Meijden, Gerhardus J.A.J.M. Kuiper, Research and Practice in Thrombosis and Haemostasis	2018	43
Diagnostic high-throughput sequencing of 2,390 patients with bleeding, thrombotic and platelet disorders Kate Downes, Karyn Mégy, Daniel Duarte,	2018	40
αIIbβ3 variants defined by next-generation sequencing: Predicting variants likely to cause Glanzmann thrombasthenia Lorena Buitrago, Augusto Rendon, Yupu Liang, Proceedings of the National Academy of Sciences	2015	39
Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients Minka J. A. Vries, Heleen Bouman, Renske H. Olie, European Heart Journal - Cardiovascular Pharmacotherapy	2016	35
Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy C. P. D. M. de Breet, Suzanne Zwaveling, Minka J. A. Vries, Frontiers in Cardiovascular Medicine	2021	15
Assessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptoms Minka J. A. Vries, Fraser L. Macrae, Patricia J. Nelemans, Thrombosis Research ThrombosisMild Bleeding SymptomsHematologyHemostasisFibrinolysis	2018	13
The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy Anne‐Marije Hulshof, Minka J. A. Vries, Paul Verhezen, Platelets Inhibitor PercentageAdp Assay ResultsProstaglandin E1PharmacotherapyMultiplate Adp Assay	2020	13

Page 1